Again, both 21NT and BT474 showed an increase in PML post treatment with epitalon to levels higher than the untreated controls (Fig. 3), suggesting that ALT has been activated and is responsible for the increase in telomere length seen in the cancer cells. The gene discussed is PML; the disease is cancer.